Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | 225Ac-FPI-1966 |
Synonyms | |
Therapy Description |
225Ac-FPI-1966 is a radioconjugate comprising vofatamab, a monoclonal antibody that targets FGFR3, linked to the radionuclide Actinium-225, which delivers radiation to tumor cells, potentially resulting in cytotoxic effects (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
225Ac-FPI-1966 | 225Ac-Vofatamab|[225Ac]-FPI-1966|actinium-225 vofatamab | 225Ac-FPI-1966 is a radioconjugate comprising vofatamab, a monoclonal antibody that targets FGFR3, linked to the radionuclide Actinium-225, which delivers radiation to tumor cells, potentially resulting in cytotoxic effects (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|